Abstract Introduction

1
Myocardial ischemia is the major cause of sports-related sudden cardiac death in recreational 2 athletes ≥ 35 years of age 1 2 . Most individuals suffering from sports-related sudden cardiac 3 death are asymptomatic or fail to recognize warning symptoms prior to the event 3 . Therefore, 4 the identification of these subjects is challenging. Elevated resting cardiac troponin (cTn) 5 levels are associated with an increased risk of an adverse cardiovascular (CV) event [4] [5] [6] . Thus, 6 it is reasonable to assume that exercise-induced cTn levels may be used to evaluate CV risk 7 during exercise. However, following strenuous physical exercise, there is a physiological 8 increase in cTn levels in healthy individuals [7] [8] [9] [10] [11] . This physiological increase may mask a 9 pathological response and preclude the use of exercise-induced cTn elevation as a risk 10 marker. Thus, the clinical interpretation of post-exercise cTn levels is problematic. 11
Recently, we published a pilot study demonstrating that the highest exercise-induced 12 cTn levels were present in asymptomatic subjects with obstructive coronary artery disease 13 (CAD) 12 . However, only 13 subjects were assessed by coronary computed tomography 14 angiography (CCTA) in that study. The present study explores the potential diagnostic role of 15 cTn assessment following strenuous exercise in a larger subset of presumably healthy 16 individuals included in the North Sea Race Endurance Exercise Study 2014 13 . The main aim 17 of the present study was to compare the exercise-induced cTn profiles in presumably healthy 18 recreational cyclists with and without coronary artery obstruction identified by CCTA. 19 20 21 22
Methods
1
Design and study population 2
The current study used CCTA to identify obstructive CAD in a subset of 120 subjects 3 participating in the NEEDED 2014 main-study (n=1002) 13 . All study participants were 4 asymptomatic, recreational cyclists participating in the 91-km North Sea mountain bike race. 5
Screening and patient inclusion are presented in Figure 1 . Inclusion and exclusion criteria 6 have been reported previously 13 . Blood samples, clinical assessments, blood pressure 7 measurements, and ECGs were obtained the day before (baseline) and at 3 and 24 h following 8 the race. The study complied with the Declaration of Helsinki and was approved by the 9
Regional Ethics Committee (REK 2013/550). All participants signed informed consent forms 10 prior to enrollment into the study. 11
Selection of subjects for coronary computed tomography angiography 12
Study subjects were selected for the present sub-study based upon their maximal cardiac 13 troponin I (cTnI) value following the race. Two different subcohorts were studied. The first 14 cohort (High-cTnI group) consisted of the 80 subjects with the highest cTnI values (from the 15 total NEEDED 2014 population, n=1002) at any time-point following the race. This cohort 16 was assessed by CCTA within a few weeks following the race. The second cohort consisted 17 of a Reference group of 40 subjects with maximal cTnI values that reflected the values of the 18 remaining NEEDED 2014 population (n=922). The reference population selection was based 19 on a representative 20/80% (Female/Male) sex-distribution, with each subject matched from 20 the NEEDED 2014 population according to age. The reference group was assessed by CCTA 21 within a year following the race. 22
Blood samples 1
Venous blood samples were drawn from the antecubital vein at baseline and at 3 and 24 h 2 after the race. Cardiac TnI (serum) was analyzed within 24 h at Stavanger University Hospital 3 on an Architect i2000SR using the high-sensitive cTnI STAT assay, which has a lower limit 4 of detection of 1.6 ng/L and a 99 th percentile of 26 ng/L (Abbott Diagnostics, IL USA) 14 . 5
Serum was frozen at -80 °C until thawed and analyzed for cardiac troponin T (cTnT) on a 6 Cobas e601; this assay has a limit of blank of 3 ng/L and a 99 th percentile of 14 ng/L (Roche 7 Diagnostics, Switzerland) 14 . 8
Coronary computed tomography angiography 9
Coronary calcification and CCTA were obtained using a Siemens Somatom Definition Flash 10 Dual Source. Obstructive CAD was defined as ≥ 50% luminal stenosis in the left coronary 11 artery, the right coronary artery, the circumflex artery, or a diagonal or marginal branch. The 12 CCTA examinations were independently assessed by two experienced radiologists, blinded to 13 the cTn findings. Non-obstructive CAD was defined as a luminal narrowing of 1-50%. 14 Subjects with obstructive CAD on CCTA were referred for conventional coronary 15 angiography and treated with percutaneous coronary intervention or coronary artery bypass 16 grafting, as determined by the cardiologist performing the angiography. 17
Statistical analysis 18
Normally distributed continuous variables are reported as the mean ±SD, while continuous 19 variables with markedly skewed distributions are reported as the median and interquartile 20 range (25 th percentile-75 th percentile). The Shapiro-Wilk test was used to test for normality. 21
The Chi-Square test, Fisher's Exact test, Student t-test, or Mann-Whitney U test was used for 22 comparison of groups, as appropriate. A two-tailed p-value < 0.05 was considered significant. 23
For statistical analyses, the statistical software programs SPSS version 24, "R", and GraphPad 24 7 1 2 3
Results
1
Participants were 45.4 (36.3-52.3) years old and 74.2% were male. The race duration was 3.6 2 (3.4-4.1) h. Subjects in the High-cTnI and the Reference groups had similar ages, gender and 3 body mass indexes (Table 1) . None of the subjects reported CV symptoms during or 4 following the race. The CCTA identified nine subjects with obstructive CAD, who all had 5 normal ECGs at baseline and 3 h after the race. However, at 24 h following the race, two 6 subjects had new T-wave inversions (V2/V4-6) and one had high precordial T-waves. Two 7 subjects in the High-cTnI group had myocardial bridging, and were excluded from the 8 analysis due to the uncertain clinical implication of this finding. Their characteristics are, 9 however, included in Table 2 . 10
Troponin profiles 11
High-cTnI subjects had maximum cTnI concentration after the race ranging from 196-7919 12 ng/L (Supplementary Figure 1) . Most High-cTnI subjects achieved maximum cTnI values at 13 3h following the race (n=78, 97.5%). The Reference group had a maximum cTnI range of 7-14 189 ng/L (Supplementary Figure 1) . All Reference group subjects achieved maximum cTnI 15 concentrations at 3 h following the race. Overall, cTnI concentrations increased markedly 16 from baseline (2.7 [1.6-6.9] ng/L) to 3 h after the race (224 [125-304] ng/L) in 98.3% of study subjects at 3 h, and 75.8% at 24 h following the race. 22
Coronary computed tomography angiography findings 1
In total, 80 of the 120 subjects (67 %) had normal coronary arteries, two had myocardial 2 bridging (1.7 %), and 39 had CAD (32.5 %, this number includes one subject who also had 3 myocardial bridging, Figure 2 ). Non-obstructive CAD was present in 15 subjects in the High-4 cTnI group (18.8 %), including one with myocardial bridging, and in 15 subjects (37.5 %) in 5 the Reference group. A total of eight subjects (10.0%) had obstructive CAD in the High-cTnI 6 group; whereas, one subject (2.5%) had obstructive CAD in the Reference group. 7
The median CAC score of the High-cTnI group was 0 (0-0) Agatston Units, vs 0 (0-11) 8
Agatston Units in the Reference group, p=0.132. When only subjects with CAD were 9 assessed, the CAC scores were 36 (2-187) Agatston Units in the High-cTnI group vs 18 (4-10 71) Agatston Units in the Reference group, p=0.72. One subject (Subject F) was only imaged 11 by conventional coronary angiography and was not included in this analysis. 12
The odds ratio (OR) for obstructive CAD between the two cohorts was: 4.46 (95% CI: 0.54-13 37.0), p=0.17. 14
Troponin concentrations in relation to coronary anatomy and pathology 15
Both cTnI and cTnT levels were significantly higher 24 h following the race in subjects with 16 obstructive CAD compared with the rest of the cohort (Figure 3 , Supplementary Table 1): 17 cTnI: p=0.005, cTnT: p=0.002 (n=118). There was no between-group difference in the cTn 18 values at baseline or at 3 h following the race. Within the High-cTnI group, subjects with 19 obstructive CAD (n=8) still had significantly higher cTn values at 24 h after the race than the 20 rest of the group (cTnI: p=0.006, cTnT: p=0.004, Supplementary Table 2) . 21
Only cTn values at 24 h after the race significantly predicted the presence of obstructive 22 CAD: cTnI: area under the curve (AUC) of 0.78, p=0.005; cTnT: 0.82, p=0.002 (Figure 4) . 23
24
Discussion
1
This study has several novel and important findings: First, both cTnI and cTnT levels were 2 significantly higher 24 h following the race in subjects with obstructive CAD compared with 3 those without coronary artery obstruction. Second, there was no difference in cTn levels 4 between subjects with and without coronary artery obstruction prior to or 3 h following the 5 race. Third, none of the subjects with obstructive CAD reported symptoms suggestive of CAD 6 during or following the race. Our findings are in line with the pilot study but add to previous 7 data suggesting that subjects with obstructive CAD have a different cTn profile than the 8 physiological cTn response, with a prolonged cTn release resembling an ischemic injury 9 pattern. These findings, however, need to be confirmed by future studies before they can be 10 used in a clinical context. 11
12
Troponin profiles in subjects with and without obstructive CAD 13 A total of nine subjects with obstructive CAD were identified in the present study, eight of 14 whom were in the High-cTn group (Table 2) . Additionally, two persons with myocardial 15 bridging, both in the High-cTn group, were excluded from the analysis due to the unclear 16 implications of this characteristic in this setting (23). Physiological exercise-induced cTn 17 elevation is thought to be due to increased myocardial stress generating a leakage of loosely 18 bound cTn into the blood stream by cytoplasmic blebbing, release of microparticles, increased 19 membrane permeability, or activation of apoptosis of cardiomyocytes 11, 15, 16 . Exercise-20 induced cTn elevation peaks at 3-6 h (cTnI) and 2-5 h (cTnT) following exercise 11, 17, 18 . 21
These peaks differ from the later rise in cTn levels following myocardial infarction. After 22 myocardial infarction, there is a release of structural cTn due to cellular necrosis, with a rapid 23 increase in cTn levels, reaching maximum values 11-12 h following revascularization 19, 20 . 24
The later peak in cTn levels following myocardial infarction reflects a slower release of 1 structural cTn due to destruction of cellular components and a prolonged washout 20 . In the 2 present study, the prolonged elevation of cTn levels in subjects with obstructive CAD may 3 suggest a different mechanism of cTn release than the short-term physiological cTn response. 4
Although no additional determination of myocardial ischemia was performed in the present 5 study, it is possible that the prolonged cTn elevation following exercise in subjects with 6 obstructive CAD is due to the development of demand ischemia during exercise. This is in 7 line with the findings of Kim et al. who found demand ischemia to be the most frequent 8 mechanism of sport-related sudden cardiac arrest 21 . This important finding warrants further 9 investigation into the relationship between demand ischemia and the cTn response following 10 strenuous exercise. 11
The absence of ischemic symptoms during strenuous exercise 12
Preventing deaths due to myocardial ischemia in recreational athletes is challenging, both due 13 to the low event rate and the frequent lack of recognizable warning symptoms prior to the 14 event 3, 22, 23 . In the study by Smallmann et al., only 17 % of subjects > 35 years of age who 15 suffered a sport-related cardiac death had reported chest pain in the 6 months leading up to the 16 event, despite the fact that most of these deaths were attributed to atherosclerotic heart 17 disease
. 18
During strenuous exercise, there are alterations in pain perception that may suppress 19 symptoms and preclude an early clinical diagnosis [24] [25] [26] . In the present study, none of the 20 subjects reported chest pain during the consultation with the cardiologists at 3 or 24 hours 21 following the race. At 24 hours after the race, Subject F had new T-wave inversions in leads V2-3 22 and highly elevated cTnI. He was admitted to hospital for a conventional coronary angiography 23 and during the hospitalization he retrospectively reported some chest discomfort during the race, 24 despite having finished the race faster than expected. His case underscores the challenges related 1 to the symptom-based CV evaluation strategy of athletes. 2
The use of regular training or competitive events to determine the risk of demand 3 ischemia 4
Most previous studies have not been able to demonstrate a significant difference in the cTn 5 response between subjects with and without evidence of ischemia using standardized stress-6 or perfusion tests 27, 28 . During prolonged strenuous exercise, there are major changes in 7 hemodynamics, neuro-endocrine activation, acid-base status, and metabolism that may induce 8 demand ischemia 21, 29 . These factors are not addressed by current routine exercise or stress 9 tests that are mostly of short duration with limited exposure to high intensity work. The 10 present study suggests there is diagnostic potential for using field-data in the detection of 11 obstructive CAD in asymptomatic individuals. Recreational athletes perform numerous 12 sessions of prolonged, high-intensity exercise both during training and competitive events that 13 may be used to evaluate risk. During these sessions, athletes are exposed to far more vigorous 14 exercise than in traditional stress tests assessing ischemia. Also, repeated assessments of the 15 exercised-induced cTn response in connection with exercise sessions may lead to personal 16 exercise cTn profiles that may be used to monitor the athlete. 17
A major challenge in the use of real-life data is the need for sufficiently accurate 18 quantification of the amount physical work performed. Future studies need to clarify the 19 relationship between exercise-induced cTn release and exercise intensity and duration by 20 direct measurement of work. Failure to perform enough work to induce demand ischemia may 21 possibly explain the low 24 h cTn levels of subject C and I in the present study (Table 2) . 22
Limitations 1 For logistic reasons, it was only possible to examine 80 individuals with CCTA within the 2 first weeks following the race. The 40 subjects in the Reference population were examined 3 later. There was one subject with obstructive CAD in the Reference population (Subject C). 4
Due to the late CCTA assessment of this subject (almost a year following the race), it is not 5 possible to determine if the coronary artery stenosis was present at the time of the race. 6
Due to logistic challenges with the large sample size of the original study (n=1002), blood 7 sampling was limited to 24 h before and 3 and 24 h after the race. 8
Long-term follow-up is needed in order to assess the association between exercise-induced 9 cTn elevation and future CV events. Follow-up studies are planned for the entire NEEDED 10 2014 cohort (n=1002) at 5, 10 and 20 years after the race to determine the long-term 11 prognostic role for prolonged cTn elevation. The results of this study need to be confirmed by 12 future studies before specific recommendations regarding the clinical use of exercise-induced 13 troponin elevation can be made. 14 15
Conclusion
16
In this prospective observational study, cTn levels 24 h after strenuous exercise were higher in 17 asymptomatic subjects with obstructive CAD compared with subjects with no coronary artery 18 obstruction. The diagnostic role of delayed post-exercise cTn elevation remains to be 19 determined in future studies. Table 1 2 Baseline characteristics of subjects included in the study. P-value signifies differences 3 between the High-cTnI group and the Reference group. The two subjects with myocardial 4 bridging in the High-cTnI group were not included. 5 
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